Sanofi SA (NASDAQ:SNY)
| 52.65 Delayed Data As of Jun 29 |  +0.53 / +1.02%Today’s Change | 46.93 Today|||52-Week Range 58.10 | +5.09% Year-to-Date |
Latest SNY News | Press Releases
| Investors Need Not Be Alarmed by Drug Patent Expirations Jun 28 / GuruFocus News - Paid Partner Content | Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA Jun 25 / MotleyFool.com - Paid Partner Content |
| Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe Jun 28 / Zacks.com - Paid Partner Content | Why Sanofi May Be a Frontrunner in Endemic COVID-19 Jun 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 52.14 |
| Today’s open | 52.63 |
| Day’s range | 52.45 - 52.88 |
| Volume | 1,813,854 |
| Average volume (3 months) | 2,233,940 |
| Market cap | $134.0B |
Data as of 5:09pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | -47.56% |
| Earnings growth (this year) | -96.15% |
| Earnings growth (next 5 years) | +8.75% |
| Revenue growth (last year) | +8.63% |
| P/E ratio | 20.4 |
| Price/Sales | 2.82 |
| Price/Book | 1.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | -0.01 | -0.02% |
| BMYBristol-Myers Squibb | -0.01 | -0.01% |
| ZTSZoetis Inc | +3.80 | +2.23% |
| ---- |
Data as of 7:29pm ET, 06/29/2022
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $44.6B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
